| Effect | Decrease |
| Trial Design | Cohort |
| Trial Length | 6+ Months |
| Number of Subjects | 24 |
| Sex | Both Genders |
Topical application of a cream containing 0.4% Ajoene daily for six months (on the BCC as well as 1cm surrounding it) in persons with either nodular or superficial tumors was able to reduce the size of the tumor in 21 out of 24 patients by a median value of 47% (42% in nodular and 55% in superficial) and reduced Bcl-2 expression also by 47% (39% nodular and 50% superficial).
